Evidence map›Paper›PMID 39351263›Full record

ArticleWorld journal of stem cells2024

Mechanism of mesenchymal stem cells in liver regeneration: Insights and future directions.

Yu-Xin Jin, Hang-Qi Hu, Jia-Cheng Zhang, Xi-Yan Xin, Yu-Tian Zhu, Yang Ye, Dong Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of stem cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu-Xin JinDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.
Hang-Qi HuDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.
Jia-Cheng ZhangDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.
Xi-Yan XinDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.
Yu-Tian ZhuDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.
Yang YeDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China. yeyang89@bjmu.edu.cn.
Dong LiDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are a prevalent source for stem cell therapy and play a crucial role in modulating both innate and adaptive immune responses. Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of triglycerides in liver cells and involves immune system activation, leading to histological changes, tissue damage, and clinical symptoms. A recent publication by Jiang

Indexed as

Immune cellsLiver regenerationMesenchymal stem cellsNon-alcoholic fatty liver diseaseTherapeutic strategy

Identifiers

PMID39351263
PMCPMC11438733

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.